MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
0.6606
-0.0144 (-2.13%)
Aug 5, 2026, 12:11 PM EDT - Market open
MIRA Pharmaceuticals Market Cap
MIRA Pharmaceuticals has a market cap or net worth of $27.76 million as of August 5, 2026. Its market cap has decreased by -4.27% in one year.
Market Cap
27.76M
Enterprise Value
18.75M
1-Year Change
-4.27%
Ranking
Category
Stock Price
$0.66
ChartMarket Cap Chart
Since the IPO on August 3, 2023, MIRA Pharmaceuticals's market cap has decreased from $103.22M to $27.76M, a decrease of -73.11%. That is a compound annual growth rate of -35.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 27.76M | -56.10% |
| Dec 31, 2025 | 63.23M | 234.93% |
| Dec 31, 2024 | 18.88M | 21.65% |
| Dec 29, 2023 | 15.52M | -84.96% |
| Aug 3, 2023 | 103.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 142.54B |
| Bristol-Myers Squibb Company | 133.41B |
| GSK plc | 104.18B |
| Sanofi | 102.63B |
| Biogen | 29.99B |
| Grifols | 6.84B |
| Organon & Co. | 3.56B |
| Amarin Corporation | 301.21M |